Respiratory and cardiovascular effects of doxapram and theophylline for the treatment of asphyxia in neonatal calves

Theriogenology

Volumn 73, Issue 5, 2010, Pages 612-619

  Bleul, U ^a   Bircher, B ^a   Jud, R S ^a   Kutter, A P N ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Asphyxia; Bovine; Doxapram; Neonate; Respiratory stimulant; Theophylline

Indexed keywords

DOXAPRAM; RESPIRATORY TRACT AGENT; THEOPHYLLINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; ASPHYXIA; BLOOD PRESSURE; BREATHING RATE; CARDIOVASCULAR SYSTEM; CATTLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART RATE; LUNG CIRCULATION; MALE; NEWBORN; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYSTEM; SINGLE BLIND PROCEDURE; VASCULAR RESISTANCE;

ANIMALS; ANIMALS, NEWBORN; ASPHYXIA; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CATTLE; DOXAPRAM; FEMALE; HEART RATE; MALE; PULMONARY CIRCULATION; RESPIRATORY RATE; RESPIRATORY SYSTEM; RESPIRATORY SYSTEM AGENTS; SINGLE-BLIND METHOD; THEOPHYLLINE; VASCULAR RESISTANCE;

BOS TAURUS; BOVINAE;

EID: 75949104426     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2009.10.017     Document Type: Article

References (44)

1. Szenci O. Role of acid-base disturbances in perinatal mortality of calves: a review. Vet Bull 73 (2003) 7R-14R
2. Daniel S.S., Dawes G.S., James L.S., and Ross B.B. Analeptics and the resuscitation of asphyxiated monkeys. BMJ 2 (1966) 562-563
3. Phillips B., Zideman D., Wyllie J., Richmond S., and van Reempts P. A statement from the Paediatric Life Support Working Group and approved by the Executive Committee of the European Resuscitation Council: European Resuscitation Council Guidelines 2000 for Newly Born Life Support. Resuscitation 48 (2001) 235-239
4. Knottenbelt DC, Holdstock N, Madigan JE. The foal at delivery. In: Equine Neonatology, W.B. Saunders, 2001, pp. 71-74.
5. Webb A.I. Neonatal resuscitation. In: Koterba A.M., and Drummond W.H. (Eds). Equine Clinical Neonatology (1990), Lippincott Williams & Wilkins 136-150
6. Bleul U., Bachofner C., Stocker H., Hassig M., and Braun U. Comparison of sodium bicarbonate and carbicarb for the treatment of metabolic acidosis in newborn calves. Vet Rec 156 (2005) 202-206
7. Herfen K. Überprüfung verschiedener Therapiemodelle bei der neonatalen Atemdepression des Kalbes unter Berücksichtigung klinischer und blutgasanalytischer Vitalitätskriterien. Med vet Thesis. Giessen, 1997.
8. Richter BR. Prognostische Aussagekraft arterieller gegenüber venöser Blutgasparameter im wiederholten Messrhythmus hinsichtlich des Schweregrades des neonatalen Atemnotsyndroms beim Kalb. Med vet Thesis. Giessen, 2005.
9. Giguere S., Sanchez L.C., Shih A., Szabo N.J., Womble A.Y., and Robertson S.A. Comparison of the effects of caffeine and doxapram on respiratory and cardiovascular function in foals with induced respiratory acidosis. Am J Vet Res 68 (2007) 1407-1416
10. Giguere S., Slade J.K., and Sanchez L.C. Retrospective comparison of caffeine and doxapram for the treatment of hypercapnia in foals with hypoxic-ischemic encephalopathy. J Vet Int Med 22 (2008) 401-405
11. Grove-Withe D. Resuscitation of the newborn calf. In Practice 2000;22:17-23.
12. Kersting K. Postpartum care of cow and calf. In: Youngquist R.S., and Threlfall W.R. (Eds). Current Therapy in Large Animal Theriogenology (1997), Saunders Elsevier 324-329
13. Kochli O. Klinische Erfahrungen mit dem Atemstimulans Respirot besonders bei der Asphyxie neugeborener Kälber. Schweiz Arch Tierh 111 (1969) 28-32
14. Szenci O. The use of Dopram-V, Lobelin and Respirot in newborn calves: a preliminary note. Proceedings of the 14th World Congress on Disease of Cattle (1986) 1283
15. Carnielli V.P., Verlato G., Benini F., Rossi K., Cavedagni M., Filippone M., et al. Metabolic and respiratory effects of theophylline in the preterm infant. Arch Dis Child Fetal Neonatal Ed 83 (2000) F39-43
16. Millar D., and Schmidt B. Controversies surrounding xanthine therapy. Semin Neonatol 9 (2004) 239-244
17. Steer P.A., and Henderson-Smart D.J. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev (2000) CD000273
18. Barrington K.J., Finer N.N., Peters K.L., and Barton J. Physiologic effects of doxapram in idiopathic apnea of prematurity. J Pediatr 108 (1986) 124-129
19. Sagi E., Eyal F., Alpan G., Patz D., and Arad I. Idiopathic apnoea of prematurity treated with doxapram and aminophylline. Arch Dis Child 59 (1984) 281-283
20. Yamazaki T., Kajiwara M., Itahashi K., and Fujimura M. Low-dose doxapram therapy for idiopathic apnea of prematurity. Pediatr Int 43 (2001) 124-127
21. Löscher W, Ungemach FR, Kroker R. Pharmaka mit Wirkung auf das Zentralnervensystem. In: Grundlagen der Pharmakotherapie bei Haus- und Nutztieren, Verlag Paul Parey, 1991, pp. 37-57.
22. Zink W., and Graf B.M. Der Pulmonalarterienkatheter. Anaesthesist 50 (2001) 623-645
23. Corley KT. Validation of a new method of determining cardiac output in neonatal foals. Master's Thesis, Virginia Polytechnic Institute 2001.
24. Amory H., Desmecht D., and Linden A. Growth-induced haemodynamic changes in healthy Friesian calves. Vet Rec 132 (1993) 426-434
25. Beretta C., Faustini R., and Gallina G. Analeptic medication in domestic animals: species differences observed with doxapram and combinations of it with other stimulants. Vet Rec 92 (1973) 217-221
26. Roos R., and Genzel-Boroviczeny O. Apnoen und Bradykardien. Checkliste Neonatologie (2003), Thieme Stuttgart pp. 139-141
27. Nishino T., Mokashi A., and Lahiri S. Stimulation of carotid chemoreceptors and ventilation by doxapram in the cat. J Appl Physiol 52 (1982) 1261-1265
28. Javaheri S., Evers J.A., and Teppema L.J. Increase in ventilation caused by aminophylline in the absence of changes in ventral medullary extracellular fluid pH and carbon dioxide tension. Thorax 44 (1989) 121-125
29. Koterba A.M. Drug doses. In: Koterba A.M., and Drummond W.H. (Eds). Equine Clinical Neonatology (1990), Lippincott Williams & Wilkins 781-789
30. Funderburk W.H., Oliver K.L., and Ward J.W. Modification of cerebral blood flow in dogs with doxapram hydrochloride. Toxicol Appl Pharmacol 13 (1968) 67-75
31. Dani C., Bertini G., Pezzati M., Pratesi S., Filippi L., Tronchin M., and Rubaltelli F.F. Brain hemodynamic effects of doxapram in preterm infants. Biol Neonate 89 (2006) 69-74
32. Miletich D.J., Ivankovich A.D., Albrecht R.F., Bonnet R.F., and Reimann C.R. The effects of doxapram on cerebral blood flow and peripheral hemodynamics in the anesthetized and unanesthetized goat. Anesth Analg 55 (1976) 279-285
33. Sreenan C., Etches P.C., Demianczuk N., and Robertson C.M. Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea. J Pediatr 139 (2001) 832-837
34. Uehara H., Yoshioka H., Nagai H., Ochiai R., Naito T., Hasegawa K., and Sawada T. Doxapram accentuates white matter injury in neonatal rats following bilateral carotid artery occlusion. Neurosci Lett 281 (2000) 191-194
35. Bleul U., Lejeune B., Schwantag S., and Kahn W. Blood gas and acid-base analysis of arterial blood in 57 newborn calves. Vet Rec 161 (2007) 688-691
36. Kim S.I., Winnie A.P., Carey J.S., and Shoemaker W.C. Use of doxapram in the critically ill patient: does increased oxygen consumption reflect an oxygen dividend or an oxygen debt?. Crit Care Med 1 (1973) 252-256
37. McEvoy G.K. AHFS Drug Information (1992), American Society of Hospital Pharmacists Inc. p. 2363
38. Plumb D.C. Veterinary Drug Handbook. 4th ed. (1999), Iowa State Press p. 853
39. Meyfeldt BK. Kompensationsmechanismen im Säure-Basen-Haushalt. In: Die Blutgasfibel, Radiometer Copenhagen, 2004, pp. 82-85.
40. Bleul U. Respiratory distress syndrome in calves. Vet Clin N Am Food A 25 (2009) 179-193
41. Von Euler U.S., and Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 12 (1946) 301-320
42. Daunderer M.H. Klinische Toxikologie. Ecomed Medizin Landsberg/Lech (2001) 136-141
43. Cattarelli D., Spandrio M., Gasparoni A., Bottino R., Offer C., and Chirico G. A randomised, double blind, placebo controlled trial of the effect of theophylline in prevention of vasomotor nephropathy in very preterm neonates with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 91 (2006) F80-84
44. Heyman E., Ohlsson A., Heyman Z., and Fong K. The effect of aminophylline on the excursions of the diaphragm in preterm neonates: a randomized double-blind controlled study. Acta Paediatr 80 (1991) 308-315